EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

A sensitive and reduced-cost culture medium for recovery of Clostridioides difficile isolates with reduced fidaxomicin susceptibility from stool

Claire E Kaple, Jennifer L Cadnum, Sarah N Redmond, Annette L Jencson, Munok Hwang iD, Hosoon Choi iD, Chetan Jinadatha iD, Curtis J Donskey iD

Journal of Clinical Microbiology · 08.07.2026 · 64 (7)

DOI: 10.1128/jcm.00068-26 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 08.07.2026. Verfasst von Claire E Kaple und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Fidaxomicin, Clostridioides difficile, Culture Media, Clostridium Infections. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Veterans Affairs, American Rescue Plan Act funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emergence of resistance to fidaxomicin is a threat to current treatment algorithms for Clostridioides difficile infection (CDI), but current surveillance methods are labor-intensive and expensive. We tested the hypothesis that C. difficile Brucella agar (CDBA) media supplemented with 1 µg/mL fidaxomicin (CDBA-F1) would provide a sensitive, selective, and cost-effective method to screen stool specimens for C. difficile isolates with reduced fidaxomicin susceptibility (minimum inhibitory concentration > 2 µg/mL). Clinical stool specimens testing positive for C. difficile ( N = 126) were plated on CDBA and CDBA-F1; C. difficile isolates recovered were tested for fidaxomicin susceptibility using agar dilution. The sensitivity of CDBA-F1 in comparison to CDBA was 100% for recovery of isolates with reduced fidaxomicin susceptibility (eight of eight detected). Breakthrough growth of stool microbiota was common, but most breakthrough organisms were easily distinguishable from C. difficile by colony morphology. Use of CDBA-F1 could provide a sensitive and selective media for detection of C. difficile isolates with reduced susceptibility while substantially reducing labor and supply costs. IMPORTANCE C. difficile isolates with reduced fidaxomicin susceptibility may emerge during CDI therapy and, in some cases, result in treatment failure. We report that supplementation of C. difficile selective media with fidaxomicin results in an effective, efficient, and reduced cost method to screen stool for isolates with reduced fidaxomicin susceptibility. Use of this approach could dramatically increase capacity to conduct surveillance for reduced fidaxomicin susceptibility in C. difficile .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FidaxomicinClostridioides difficileCulture MediaClostridium InfectionsFecesAnti-Bacterial AgentsBacteriological TechniquesHumansSensitivity and SpecificityMicrobial Sensitivity TestsDrug Resistance, Bacterial

Stichwörter der Autor:innen

Clostridioides difficileculture mediumfidaxomicinsurveillancesusceptibility

Substanzen

FidaxomicinCulture MediaAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Research Service, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA.
  • Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Department of Research, Central Texas Veterans Health Care System, Temple, Texas, USA.
  • Department of Medicine, Central Texas Veterans Health Care System, Temple, Texas, USA.
  • Department of Medical Education, College of Medicine, Texas A&M University, Bryan, Texas, USA.

ORCID-Profile: Munok Hwang, Hosoon Choi, Chetan Jinadatha, Curtis J Donskey

Förderung

  • U.S. Department of Veterans Affairs
  • American Rescue Plan Act funds

Zitieren

APA

Kaple, C. E., Cadnum, J. L., Redmond, S. N., Jencson, A. L., Hwang, M., Choi, H., Jinadatha, C., & Donskey, C. J. (2026). A sensitive and reduced-cost culture medium for recovery of Clostridioides difficile isolates with reduced fidaxomicin susceptibility from stool. Journal of Clinical Microbiology, 64(7). https://doi.org/10.1128/jcm.00068-26

Vancouver

Kaple CE, Cadnum JL, Redmond SN, Jencson AL, Hwang M, Choi H, et al. A sensitive and reduced-cost culture medium for recovery of Clostridioides difficile isolates with reduced fidaxomicin susceptibility from stool. Journal of Clinical Microbiology. 2026;64(7). doi:10.1128/jcm.00068-26

BibTeX
@article{Kaple2026,
  author = {Kaple, Claire E and Cadnum, Jennifer L and Redmond, Sarah N and Jencson, Annette L and Hwang, Munok and Choi, Hosoon and Jinadatha, Chetan and Donskey, Curtis J},
  title = {A sensitive and reduced-cost culture medium for recovery of Clostridioides difficile isolates with reduced fidaxomicin susceptibility from stool},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  volume = {64},
  number = {7},
  doi = {10.1128/jcm.00068-26}
}
Kostenlos starten →